429 related articles for article (PubMed ID: 31088252)
1. Opportunities and challenges of circulating biomarkers in neuroblastoma.
Trigg RM; Shaw JA; Turner SD
Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders.
Mithraprabhu S; Chen M; Savvidou I; Reale A; Spencer A
Leukemia; 2021 Oct; 35(10):2771-2783. PubMed ID: 34262132
[TBL] [Abstract][Full Text] [Related]
3. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
4. Circulating biomarkers in patients with glioblastoma.
Müller Bark J; Kulasinghe A; Chua B; Day BW; Punyadeera C
Br J Cancer; 2020 Feb; 122(3):295-305. PubMed ID: 31666668
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research.
Ramirez-Garrastacho M; Bajo-Santos C; Line A; Martens-Uzunova ES; de la Fuente JM; Moros M; Soekmadji C; Tasken KA; Llorente A
Br J Cancer; 2022 Feb; 126(3):331-350. PubMed ID: 34811504
[TBL] [Abstract][Full Text] [Related]
6. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
[TBL] [Abstract][Full Text] [Related]
7. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; Tirrò E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
9. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy: A new avenue in pathology.
Ghosh RK; Pandey T; Dey P
Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Circulating Biomarkers of Brain Tumors.
Jelski W; Mroczko B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
[TBL] [Abstract][Full Text] [Related]
12. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
Batool SM; Yekula A; Khanna P; Hsia T; Gamblin AS; Ekanayake E; Escobedo AK; You DG; Castro CM; Im H; Kilic T; Garlin MA; Skog J; Dinulescu DM; Dudley J; Agrawal N; Cheng J; Abtin F; Aberle DR; Chia D; Elashoff D; Grognan T; Krysan K; Oh SS; Strom C; Tu M; Wei F; Xian RR; Skates SJ; Zhang DY; Trinh T; Watson M; Aft R; Rawal S; Agarwal A; Kesmodel SB; Yang C; Shen C; Hochberg FH; Wong DTW; Patel AA; Papadopoulos N; Bettegowda C; Cote RJ; Srivastava S; Lee H; Carter BS; Balaj L
Cell Rep Med; 2023 Oct; 4(10):101198. PubMed ID: 37716353
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsy: A Game Changer for Type 2 Diabetes.
Gradisteanu Pircalabioru G; Musat M; Elian V; Iliescu C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473908
[TBL] [Abstract][Full Text] [Related]
14. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
15. Emerging on-chip electrokinetic based technologies for purification of circulating cancer biomarkers towards liquid biopsy: A review.
Shi L; Esfandiari L
Electrophoresis; 2022 Jan; 43(1-2):288-308. PubMed ID: 34791687
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy for liver diseases.
Mann J; Reeves HL; Feldstein AE
Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
[TBL] [Abstract][Full Text] [Related]
19. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in circulating nucleic acids in oncology.
Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR
Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
